Co-Authors
This is a "connection" page, showing publications co-authored by Manuel Battegay and Felix Stader.
Connection Strength
0.340
-
Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect. J Antimicrob Chemother. 2020 10 01; 75(10):3084-3086.
Score: 0.226
-
Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19. Drug Saf. 2021 02; 44(2):255-257.
Score: 0.057
-
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations. Antimicrob Agents Chemother. 2020 08 20; 64(9).
Score: 0.056